Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04185272
Other study ID # IMMUNOCOL-IPC 2019-018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 30, 2020
Est. completion date June 2028

Study information

Verified date April 2022
Source Institut Paoli-Calmettes
Contact Dominique Genre, Dr
Phone 04 91 22 37 78
Email drci.up@ipc.unicancer.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

quantification of BTNL molecules in colon cancer in order to determinate if their could be used as a prognostic marquer


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 2028
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient is older than 18 years old, - Signed participation consent, - Non-metastatic colon cancer immediately resectable or metastatic and liver synchronous for which it was decided a combined colic and liver surgery (metastatic patient at the outset) in multidisciplinary consultation meeting. - Performance Status (PS) 0 or 1 - affiliated to the social security or beneficiary Exclusion Criteria: - Rectal cancer, colon cancer recurrence - Emergency of colon cancer Surgery - History of inflammatory disease of the digestive tract (Crohn's disease or ulcerative colitis) - Patient who received neoadjuvant therapy other than chemotherapy - Patient treated with immune-suppressors or long-course corticosteroids <12 months - Pregnant women or likely to be pregnant (without effective contraception) or breastfeeding, - Person in urgent situation, person under legal protection measure, or unable to express his / her consent, - Impossibility of submitting to the medical examination of the test for geographical, social or psychological reasons

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
analysis of BTN and BTNL status
analysis of BTN and BTNL expression in colon cancer and hepatic metastasis

Locations

Country Name City State
France Lopez Almeida Marseille

Sponsors (1)

Lead Sponsor Collaborator
Institut Paoli-Calmettes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary evaluation of BTNL3, BTNL8 and BTNL9 expression by transcriptomics and immunohistochemistry healthy and cancerous colon ad metastasis (if applicable) will be analysed by 8 years
See also
  Status Clinical Trial Phase
Completed NCT01339273 - Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection N/A
Terminated NCT02585271 - Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction N/A
Completed NCT06426745 - Split-dose Versus Single-dose Bowel Preparation for Colonoscopy N/A
Completed NCT00938210 - Rehabilitation Following Laparoscopic Colonic Surgery N/A
Recruiting NCT05133544 - Endocuff With or Without AI-assisted Colonoscopy N/A
Recruiting NCT03803891 - Endoscopic Full-Thickness Resection In Colon
Completed NCT03130166 - INtracorporeal Versus EXtracorporeal Anastomosis in Robotic Right Colectomy N/A
Completed NCT00280332 - A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening Colonoscopy N/A
Completed NCT03139942 - Optical Polyp Testing for In Vivo Classification N/A
Active, not recruiting NCT03446157 - Palbociclib and Cetuximab in Metastatic Colorectal Cancer Phase 2
Recruiting NCT03355495 - R vs L Lateral Decubitus Positioning in Colonoscopy N/A
Recruiting NCT04906343 - Endoscopic Surveillance in Serrated Polyposis Syndrome and Low-risk of Advanced Neoplasia N/A
Not yet recruiting NCT05303818 - Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer Phase 4
Completed NCT04683783 - National Registry of Liver First Approach
Recruiting NCT03033719 - Colectomy for Cancer in the Elderly by Laparoscopy or Laparotomy N/A
Recruiting NCT04316013 - Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial Phase 3
Completed NCT04434508 - Open Versus Laparoscopic Right Hemicolectomy for Right Colon Cancer N/A
Completed NCT01287130 - AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer Phase 1
Completed NCT02727153 - "Ultra" Enhanced Recovery After Surgery (E.R.A.S.) in Laparoscopic Colectomy for Cancer Phase 3
Completed NCT00427492 - Effect of Postoperative Laxative on Bowel Function After Colonic Surgery Phase 4